Variability in total serum IgE over 1 year in severe asthmatics

Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgEtot) in asthmatics remains p...

Source: Allergy, Asthma and Clinical Immunology - March 29, 2019 Category: Allergy & Immunology Authors: Renaud Louis, Charles Pilette, Olivier Michel, Alain Michils, Guy Brusselle, Antoine Poskin, Jan Van Schoor, Kris Denhaerynck, Stefaan Vancayzeele, Ivo Abraham and Sandra Gurdain Tags: Research Source Type: research